Archive for December, 2008

Auxilium Pharmaceuticals, Inc. Announces Initiation Of XIAFLEX(TM) Phase IIb Study For Peyronie’s Disease

Posted by poster on December 31st, 2008 under Uncategorized Tags: ,  •  Comments Off

Auxilium
Pharmaceuticals, Inc. (NASDAQ: AUXL), a specialty biopharmaceutical
company, today announced that the first patients have been dosed in
the Company’s U.S. phase IIb trial of XIAFLEX(TM) for the treatment
of Peyronie’s disease. Peyronie’s disease is the development of a
collagen plaque, or scar tissue, on the shaft of the penis that
hardens and reduces flexibility, causing the penis to bend

Pharmacy Chain Allows Men To Get Erectile Dysfunction Drugs Without Visiting Their GP, UK

Posted by poster on December 31st, 2008 under Uncategorized Tags: , , , , , ,  •  Comments Off

A new service which allows men to get erectile dysfunction drugs legitimately without having to visit their GP for a prescription has been launched.
The new service - a UK first - is being launched by Lloydspharmacy in partnership with sexual health experts Dr Thom, The service offers online diagnosis of erectile problems

Drug Designed To Lower Uric Acid Levels May Be Useful For Hypertension

Posted by poster on December 30th, 2008 under Uncategorized Tags: , , , ,  •  Comments Off

According to a report published in the August 27 issue of JAMA,
a drug that lowers uric acid levels, allopurinol, also seems to lower
blood pressure in adolescents with newly diagnosed hypertension (high
blood pressure).
Hyperuricemia - a condition characterized by higher than normal blood
levels of uric acid

New Antihypertensive PritorPlus® 80/25 And Kinzalkomb® 80/25 Approved By EU Commission

Posted by poster on December 29th, 2008 under Uncategorized Tags: , , , , ,  •  Comments Off

Bayer Schering Pharma was granted European marketing authorization for its new antihypertensive fixed dose combination drug PritorPlus® 80/25 and Kinzalkomb® 80/25 (80 mg telmisartan/25 mg hydrochlorothiazide) by the European Commission. The new formulation will be launched in Germany later this month, to be followed soon by selected

News From The American Chemical Society Nov. 12, 2008

Posted by poster on December 28th, 2008 under Uncategorized  •  Comments Off

A faster test for the food protein that triggers celiac disease
Researchers in Spain and the United Kingdom are reporting development of a faster test for identifying the food protein that triggers celiac disease, a difficult-to-diagnose digestive disease involving the inability to digest protein called gluten that occurs in wheat, oats, rye, and barley. The finding […]

New Book Extols Benefits Of Chocolate

Posted by poster on December 26th, 2008 under Uncategorized Tags: ,  •  Comments Off

From Halloween through Valentine’s Day, chocolate helps celebrate the season. While overindulging leads to calorie concerns, the right amounts of the right kinds of chocolate can actually make one feel and even look better. Registered dietitians Shara Aaron and Monica Bearden, authors of CHOCOLATE - A HEALTHY PASSION (Prometheus Books), can explain chocolate’s role in […]

Adheris Study Finds Antidepressant Discontinuation Most Likely At The Start Of Therapy Among Newly Treated And Previously Lapsed Patients

Posted by poster on December 25th, 2008 under Uncategorized Tags: , , , , , , , ,  •  Comments Off

Adheris, Inc., a leader in patient adherence and education programs, announced today the results of a new study that examined adherence rates among patients on SSRI/SNRI antidepressant therapy.
Study results showed that patients new to antidepressant treatment

CMAJ Study Reveals Higher Anaphylaxis Rates After HPV Vaccination

Posted by poster on December 24th, 2008 under Uncategorized  •  Comments Off

The estimated rate of anaphylaxis in young women after human papillomavirus (HPV) vaccination was significantly higher - 5 to 20 fold - than that identified in comparable school-based vaccination programs, according to a study published in CMAJ Generic acomplia pills no prescription However, the overall rates of anaphylaxis were low with no associated serious

Antidepressant Medications May Have Alternate Use

Posted by poster on December 17th, 2008 under Uncategorized Tags: , , , ,  •  Comments Off

A new study published in the August 15th issue of Biological
Psychiatry finds that hippocampal neurogenesis (neuron birth
in the hippocampus part of the brain) might be used by the
monoaminergic antidepressants (related to the secretion of monoamine
neurotransmitters such as dopamine and serotonin) to counteract the
effects of stress, whereas similar effects could

Start Of Phase IIb Clinical Study With CYT003-QbG10 Monotherapy For The Treatment Of Allergic Diseases

Posted by poster on December 16th, 2008 under Uncategorized Tags: ,  •  Comments Off

Cytos Biotechnology Ltd (SIX:CYTN) announced
today that it has started a phase IIb clinical study with CYT003-QbG10, an allergen-independent
immunotherapeutic product candidate for the treatment of allergy and asthma. The study is a
randomized, double-blind, placebo-controlled, multicenter dose-finding study to evaluate the safety,
tolerability and efficacy of two different doses of CYT003-QbG10. It will include 300 patients with
rhinoconjunctivitis

Greater Risk Of Blood Pressure Disorders During Pregnancy In Rural Areas

Posted by poster on December 12th, 2008 under Uncategorized Tags: , ,  •  Comments Off

Several factors, such as older age and high weight gain, are known risk factors for pre-eclampsia and other pregnancy-related blood pressure disorders. Now a new report suggests that social factors - including living in a rural county - may also increase the risk of pre-eclampsia and pregnancy-induced hypertension (PIH), according to research presented at the […]

EPA Makes Decision To Designate Areas Not Meeting Standards For Fine Particle Pollution, USA

Posted by poster on December 11th, 2008 under Uncategorized  •  Comments Off

EPA has notified 25 governors and 23 tribal leaders that certain areas in their states and tribal lands do not meet the agency’s daily standards for fine particle pollution, also known as PM 2.5.
"These designations are an important step in our steady march toward cleaner air," said EPA Administrator Stephen L. Johnson. "We will

New Program Challenges Stigma And Honors Police Officers Who Help Each Other And Themselves To Cope With Job Stress

Posted by poster on December 10th, 2008 under Uncategorized Tags:  •  Comments Off

Generic cipro pills no prescription Mangled bodies, gunfire, high-speed chases and injured children are just a few events witnessed by police officers and soldiers serving in dangerous hot spots around the world.
The city of Cleveland’s Division of Police has partnered with Case Western Reserve University, the Partnership for a Safer Cleveland and the

Population Study Finds Genetic Clues

Posted by poster on December 10th, 2008 under Uncategorized Tags: ,  •  Comments Off

A new genome-wide study examines genetic variants associated with nine metabolic traits and is the first to draw out novel variants from a population unselected for current disease. The traits are indicators for common disease such as cardiovascular disease, type 2 diabetes, blood pressure, inflammation and lipid levels.
Cohorts are followed throughout their lives, gathering lifelong […]

De-Medicalising Misery Conference, University Of East Londond And University College London, 16 December, 2008

Posted by poster on December 10th, 2008 under Uncategorized Tags: ,  •  Comments Off

How did the medical profession and pharmaceutical industry persuade us that antidepressants worked? Does cognitive behavioural therapy really offer a cure for unhappiness? Can the psy-professions escape their legacy of racism? generic levitra online buy These and other questions will be addressed at De-Medicalising Misery, a conference organised by the University

Suicide rate among young male veterans reaches record high in 2006

Posted by poster on December 10th, 2008 under Uncategorized Tags: ,  •  Comments Off

Men’s Health News
The suicide rate among young male veterans who served during the wars in Iraq and Afghanistan reached a record high in 2006, the latest year for which records are available, according to data released on Tuesday by the Department of Veterans Affairs, USA Today reports.
According to the data, the

Link Between Paracetamol Use And Asthma In European Adults Confirmed In GA??LEN Study

Posted by poster on December 10th, 2008 under Uncategorized Tags:  •  Comments Off

Adults who take paracetamol weekly were nearly three times more likely to have asthma than those taking paracetamol less often, according to a study organised by GA??LEN, the Global Allergy and Asthma European Network. Use of other painkillers was not significantly related to asthma.
In the GA??LEN-SARI study,

Allopurinol May Lower Blood Pressure In Teens With Hypertension

Posted by poster on December 8th, 2008 under Uncategorized Tags: , , , ,  •  Comments Off

The drug allopurinol, which lowers uric acid levels, appears to reduce blood pressure in adolescents with newly diagnosed hypertension, according to a preliminary report in the August 27 issue of JAMA.
Hypertension is commonly associated with hyperuricemia (elevated blood level of uric acid, a by-product of normal chemical

Kidney Function Discovery Sheds Light On Genetic Complexity Of Disease

Posted by poster on December 8th, 2008 under Uncategorized Tags: ,  •  Comments Off

To find a cure for cancer, haemophilia and other diseases, researchers need to be looking for complex, interacting genetic factors, according to the authors of a new study.
A new study, published in the Journal of Clinical Investigation by researchers at the Centenary Institute, Royal Prince Alfred Hospital (RPA)

Single Pill Combinations Diovan HCT® And Exforge® Approved In US As First-line Treatments For High Blood Pressure

Posted by poster on December 8th, 2008 under Uncategorized Tags: , , , , , , ,  •  Comments Off

The US Food and Drug Administration (FDA) has approved two single-pill combination medications, Diovan HCT® (valsartan and hydrochlorothiazide) and Exforge® (amlodipine and valsartan), as initial or ‘first-line’ therapies in patients likely to need multiple drugs to achieve their blood pressure goals.
The FDA approval of

Re-launched Allergy Screening Service Hits The Airwaves, UK

Posted by poster on December 8th, 2008 under Uncategorized Tags:  •  Comments Off

Just under a hundred NPA members are now offering the NPA and Allergy UK Allergy Screening Service. The service which has been recently remodelled to include a "pin prick" test as well as a screen was the subject of radio interviews conducted by regional and local stations

Folic Acid In Pregnancy May Increase Risk Of Respiratory Complications

Posted by poster on December 8th, 2008 under Uncategorized  •  Comments Off

Pregnant women who take folic acid supplements may increase the risk of respiratory illness in their infants, according to an article released on December 2, 2008 in the Archives of Disease in Childhood, one of the BMJ Specialist Journals.
Folate, or

‘Mind’ Comments On Government ‘Fit Note’ Plans, UK

Posted by poster on December 7th, 2008 under Uncategorized Tags: , , , , ,  •  Comments Off

Latest News For Mental Health
Mind Comments On Government ‘Fit Note’ Plans, UK
26 Nov 2008
Guidance Issued On Improving Patient Safety In Mental Health And Learning Disability Services, UK
26 Nov 2008
‘Mind’ Comments On Government ‘Fit Note’ Plans, UK
26 Nov 2008
generic cipro

MU Researcher Develops Screening Tool To Identify Patients With Prediabetes

Posted by poster on December 7th, 2008 under Uncategorized Tags: ,  •  Comments Off

A third of Americans with diabetes do not know that they have it, and many more who have prediabetic conditions are unaware that they are at risk. Buy acomplia without prescription A University of Missouri researcher has created a clinical tool to identify those at highest risk for

Metabolex Announces Positive Results From Phase 1a Clinical Trial Of MBX-2982

Posted by poster on December 7th, 2008 under Uncategorized Tags: , , ,  •  Comments Off

Metabolex, Inc., a
biopharmaceutical company focused on the discovery and development of
proprietary new medicines for the treatment of metabolic diseases,
announced positive results from a Phase 1a clinical trial of MBX-2982. A
summary of the results was presented at the World Congress on Controversies
to Consensus […]